The global NK Cell Therapy market was valued at US$ 347.8 million in 2023 and is anticipated to reach US$ 1006.7 million by 2030, witnessing a CAGR of 16.2% during the forecast period 2024-2030.

NK Cell Therapy Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.

This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.

Report Scope

The NK Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NK Cell Therapy Market Report

Report Metric	Details
Report Name	NK Cell Therapy Market
Accounted market size in 2023	US$ 347.8 million
Forecasted market size in 2030	US$ 1006.7 million
CAGR	16.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	NK Cell Therapies NK Cell Directed Antibodies
Segment by Application	Cancer Gastrointestinal Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NK Cell Therapy Market growing?

Ans: The NK Cell Therapy Market witnessing a CAGR of 16.2% during the forecast period 2024-2030.

What is the NK Cell Therapy Market size in 2030?

Ans: The NK Cell Therapy Market size in 2030 will be US$ 1006.7 million.

What is the NK Cell Therapy Market share by region?

Ans: North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.

What is the market share of major companies in NK Cell Therapy Market?

Ans: Top 3 companies occupied about 82% market share.

Who are the main players in the NK Cell Therapy Market report?

Ans: The main players in the NK Cell Therapy Market are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech

What are the Application segmentation covered in the NK Cell Therapy Market report?

Ans: The Applications covered in the NK Cell Therapy Market report are Cancer, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the NK Cell Therapy Market report?

Ans: The Types covered in the NK Cell Therapy Market report are NK Cell Therapies, NK Cell Directed Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global NK Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cancer

1.3.3 Gastrointestinal Diseases

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global NK Cell Therapy Market Perspective (2019-2030)

2.2 NK Cell Therapy Growth Trends by Region

2.2.1 Global NK Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NK Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 NK Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 NK Cell Therapy Market Dynamics

2.3.1 NK Cell Therapy Industry Trends

2.3.2 NK Cell Therapy Market Drivers

2.3.3 NK Cell Therapy Market Challenges

2.3.4 NK Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NK Cell Therapy Players by Revenue

3.1.1 Global Top NK Cell Therapy Players by Revenue (2019-2024)

3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NK Cell Therapy Revenue

3.4 Global NK Cell Therapy Market Concentration Ratio

3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2023

3.5 NK Cell Therapy Key Players Head office and Area Served

3.6 Key Players NK Cell Therapy Product Solution and Service

3.7 Date of Enter into NK Cell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NK Cell Therapy Breakdown Data by Type

4.1 Global NK Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global NK Cell Therapy Forecasted Market Size by Type (2025-2030)

5 NK Cell Therapy Breakdown Data by Application

5.1 Global NK Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global NK Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NK Cell Therapy Market Size (2019-2030)

6.2 North America NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America NK Cell Therapy Market Size by Country (2019-2024)

6.4 North America NK Cell Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NK Cell Therapy Market Size (2019-2030)

7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe NK Cell Therapy Market Size by Country (2019-2024)

7.4 Europe NK Cell Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NK Cell Therapy Market Size (2019-2030)

8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NK Cell Therapy Market Size (2019-2030)

9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America NK Cell Therapy Market Size by Country (2019-2024)

9.4 Latin America NK Cell Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NK Cell Therapy Market Size (2019-2030)

10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nektar Therapeutics

11.1.1 Nektar Therapeutics Company Detail

11.1.2 Nektar Therapeutics Business Overview

11.1.3 Nektar Therapeutics NK Cell Therapy Introduction

11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.1.5 Nektar Therapeutics Recent Development

11.2 Innate Pharma SA

11.2.1 Innate Pharma SA Company Detail

11.2.2 Innate Pharma SA Business Overview

11.2.3 Innate Pharma SA NK Cell Therapy Introduction

11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2019-2024)

11.2.5 Innate Pharma SA Recent Development

11.3 Affimed

11.3.1 Affimed Company Detail

11.3.2 Affimed Business Overview

11.3.3 Affimed NK Cell Therapy Introduction

11.3.4 Affimed Revenue in NK Cell Therapy Business (2019-2024)

11.3.5 Affimed Recent Development

11.4 Chipscreen Biosciences

11.4.1 Chipscreen Biosciences Company Detail

11.4.2 Chipscreen Biosciences Business Overview

11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction

11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2019-2024)

11.4.5 Chipscreen Biosciences Recent Development

11.5 Fate Therapeutics

11.5.1 Fate Therapeutics Company Detail

11.5.2 Fate Therapeutics Business Overview

11.5.3 Fate Therapeutics NK Cell Therapy Introduction

11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.5.5 Fate Therapeutics Recent Development

11.6 Glycostem Therapeutics

11.6.1 Glycostem Therapeutics Company Detail

11.6.2 Glycostem Therapeutics Business Overview

11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction

11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.6.5 Glycostem Therapeutics Recent Development

11.7 Dragonfly Therapeutics

11.7.1 Dragonfly Therapeutics Company Detail

11.7.2 Dragonfly Therapeutics Business Overview

11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction

11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.7.5 Dragonfly Therapeutics Recent Development

11.8 Kiadis Pharma

11.8.1 Kiadis Pharma Company Detail

11.8.2 Kiadis Pharma Business Overview

11.8.3 Kiadis Pharma NK Cell Therapy Introduction

11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2019-2024)

11.8.5 Kiadis Pharma Recent Development

11.9 NantWorks

11.9.1 NantWorks Company Detail

11.9.2 NantWorks Business Overview

11.9.3 NantWorks NK Cell Therapy Introduction

11.9.4 NantWorks Revenue in NK Cell Therapy Business (2019-2024)

11.9.5 NantWorks Recent Development

11.10 Nkarta Therapeutics

11.10.1 Nkarta Therapeutics Company Detail

11.10.2 Nkarta Therapeutics Business Overview

11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction

11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.10.5 Nkarta Therapeutics Recent Development

11.11 Fortress Biotech

11.11.1 Fortress Biotech Company Detail

11.11.2 Fortress Biotech Business Overview

11.11.3 Fortress Biotech NK Cell Therapy Introduction

11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2019-2024)

11.11.5 Fortress Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Nektar Therapeutics

Innate Pharma SA

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

List of Tables

Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of NK Cell Therapies

Table 3. Key Players of NK Cell Directed Antibodies

Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global NK Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global NK Cell Therapy Market Share by Region (2019-2024)

Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global NK Cell Therapy Market Share by Region (2025-2030)

Table 10. NK Cell Therapy Market Trends

Table 11. NK Cell Therapy Market Drivers

Table 12. NK Cell Therapy Market Challenges

Table 13. NK Cell Therapy Market Restraints

Table 14. Global NK Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global NK Cell Therapy Market Share by Players (2019-2024)

Table 16. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2023)

Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players NK Cell Therapy Product Solution and Service

Table 21. Date of Enter into NK Cell Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global NK Cell Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global NK Cell Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global NK Cell Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global NK Cell Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific NK Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific NK Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific NK Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Nektar Therapeutics Company Detail

Table 47. Nektar Therapeutics Business Overview

Table 48. Nektar Therapeutics NK Cell Therapy Product

Table 49. Nektar Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 50. Nektar Therapeutics Recent Development

Table 51. Innate Pharma SA Company Detail

Table 52. Innate Pharma SA Business Overview

Table 53. Innate Pharma SA NK Cell Therapy Product

Table 54. Innate Pharma SA Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 55. Innate Pharma SA Recent Development

Table 56. Affimed Company Detail

Table 57. Affimed Business Overview

Table 58. Affimed NK Cell Therapy Product

Table 59. Affimed Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 60. Affimed Recent Development

Table 61. Chipscreen Biosciences Company Detail

Table 62. Chipscreen Biosciences Business Overview

Table 63. Chipscreen Biosciences NK Cell Therapy Product

Table 64. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 65. Chipscreen Biosciences Recent Development

Table 66. Fate Therapeutics Company Detail

Table 67. Fate Therapeutics Business Overview

Table 68. Fate Therapeutics NK Cell Therapy Product

Table 69. Fate Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 70. Fate Therapeutics Recent Development

Table 71. Glycostem Therapeutics Company Detail

Table 72. Glycostem Therapeutics Business Overview

Table 73. Glycostem Therapeutics NK Cell Therapy Product

Table 74. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 75. Glycostem Therapeutics Recent Development

Table 76. Dragonfly Therapeutics Company Detail

Table 77. Dragonfly Therapeutics Business Overview

Table 78. Dragonfly Therapeutics NK Cell Therapy Product

Table 79. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 80. Dragonfly Therapeutics Recent Development

Table 81. Kiadis Pharma Company Detail

Table 82. Kiadis Pharma Business Overview

Table 83. Kiadis Pharma NK Cell Therapy Product

Table 84. Kiadis Pharma Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 85. Kiadis Pharma Recent Development

Table 86. NantWorks Company Detail

Table 87. NantWorks Business Overview

Table 88. NantWorks NK Cell Therapy Product

Table 89. NantWorks Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 90. NantWorks Recent Development

Table 91. Nkarta Therapeutics Company Detail

Table 92. Nkarta Therapeutics Business Overview

Table 93. Nkarta Therapeutics NK Cell Therapy Product

Table 94. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 95. Nkarta Therapeutics Recent Development

Table 96. Fortress Biotech Company Detail

Table 97. Fortress Biotech Business Overview

Table 98. Fortress Biotech NK Cell Therapy Product

Table 99. Fortress Biotech Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 100. Fortress Biotech Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NK Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global NK Cell Therapy Market Share by Type: 2023 VS 2030

Figure 3. NK Cell Therapies Features

Figure 4. NK Cell Directed Antibodies Features

Figure 5. Global NK Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global NK Cell Therapy Market Share by Application: 2023 VS 2030

Figure 7. Cancer Case Studies

Figure 8. Gastrointestinal Diseases Case Studies

Figure 9. Others Case Studies

Figure 10. NK Cell Therapy Report Years Considered

Figure 11. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global NK Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global NK Cell Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global NK Cell Therapy Market Share by Players in 2023

Figure 15. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2023

Figure 17. North America NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America NK Cell Therapy Market Share by Country (2019-2030)

Figure 19. United States NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe NK Cell Therapy Market Share by Country (2019-2030)

Figure 23. Germany NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific NK Cell Therapy Market Share by Region (2019-2030)

Figure 31. China NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America NK Cell Therapy Market Share by Country (2019-2030)

Figure 39. Mexico NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa NK Cell Therapy Market Share by Country (2019-2030)

Figure 43. Turkey NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 46. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 47. Affimed Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 48. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 49. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 50. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 51. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 52. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 53. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 54. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 55. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions